THE Therapeutic Goods
Administration has designated
Prizer’s Sutent (sunitinib maleate)
as an orphan drug.
Sutent is indicated for the
treatment of pancreatic
nuroendocrine tumours, and is
available in 12.5mg, 25mg,
37.5mg and 50mg capsules.
More info at www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 13 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 May 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.